4//SEC Filing
Allouche Cyril 4
Accession 0001479290-18-000116
CIK 0001479290other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:17 PM ET
Size
4.9 KB
Accession
0001479290-18-000116
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Tax Payment
Common Stock
2018-11-15$20.99/sh−259$5,436→ 4,491 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the issuer on November 15, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of a 2016 Restricted Stock Award ("RSA") for 3,000 shares. The RSA vests in four equal annual installments from November 15, 2016, subject to Mr. Allouche's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001744573
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 6:17 PM ET
- Size
- 4.9 KB